<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>A Missense Mutation PRPF6 Causes <br /> Impairment pre-mRNA Splicing Autosomal-Dominant Retinitis Pigmentosa <br />  <br />  <br /> Retinitis pigmentosa (RP) inherited form retinal degeneration leads progressive visual-field constriction blindness. disease manifests retina, mutations ubiquitously expressed genes associated tri-snRNP complex spliceosome identified patients dominantly inherited RP. screened mutations PRPF6 (NM_012469.3), gene chromosome 20q13.33 encoding essential protein tri-snRNP assembly stability, 188 unrelated patients auto- <br /> somal-dominant RP identified missense mutation, c.2185C&gt;T (p.Arg729Trp). change affected residue conserved humans yeast cosegregated disease family identified. Lymphoblasts derived patients mutation showed abnormal localization endogenous PRPF6 nucleus. Specifically, protein accumulated Cajal <br /> bodies, indicating possible impairment tri-snRNP assembly recycling. Expression GFP-tagged PRPF6 HeLa cells showed phenomenon depended exclusively mutated form protein. Furthermore, analysis endogenous transcripts cells patients revealed intron retention pre-mRNA bearing specific splicing signals, according pattern displayed lymphoblasts mutations PRPF genes. results identify PRPF6 sixth gene involved pre-mRNA splicing dominant RP, corroborating hypothesis deficiencies spliceosome play important role molecular pathology disease. <br />  <br /> Mutations 50 genes cause retinitis pigmentosa                involve dynamic assembly disassembly snRNP <br /> (RP [MIM 268000]), form retinal degeneration                 subcomplexes. round splicing, U4/ <br /> estimated prevalence 1 ~4,000 individuals.1,2 Patients              U6.U5 complex  tri-snRNP) assembled condition experience progressive decline                   interaction U4/U6 di-snRNP U5, medi- <br /> retinal function, usually starting night blindness,                  ated splicing factors PRPF31 PRPF6.14,15  leads complete loss vision end                ingly, pre-mRNA splicing factor genes associated <br /> stage.3 RP inherited dominant, recessive, X-linked             adRP encode components tri-snRNP  trait rarely non-Mendelian phenotype.4                  exception RP9, proven affect course disease slowed <span id='am-1' about='obo:IMR_0001656' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0001656" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="CHEBI:27305" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="vitamin" datatype="xsd:string"></span>vitamin</span> supple-                assembly disassembly particle.16&#226;&#8364;&#8220;20 mentation.5 genes associated nonsyndromic RP                    tri-snRNP, PRPF6 acts molecular bridge retina-prevalent expression produce proteins                U5 snRNP di-snRNP.15 Furthermore, data clear biochemical structural role               electron microscopy protein-protein interaction <br /> retinal retinal pigment epithelium cells. RP                 analyses21,22 indicate PRPF6 binds 4 5 tri- <br /> genes,  widespread expression pattern                 snRNP proteins involved adRP, constituting struc- present human tissues nonetheless cause                 tural heart particle itself (Figure 1). basis ocular-restricted symptoms.1                                              previous biochemical knowledge protein    respect ubiquitously expressed genes, mutations                involvement tri-snRNP components adRP, cause autosomal-dominant RP (adRP) encode                    reasoned PRPF6 good candidate gene PRPF31 (MIM 606419), PRPF8 (MIM 607300), PRPF3                            condition. <br /> (MIM 607301), RP9 (MIM 607331), hBRR2 (MIM                              screened mutations 21 exons gene 601664),6&#226;&#8364;&#8220;12 e., dozen proteins                 chromosome 20q13.33 index patients 188 families <br /> composing spliceosome, machinery essential                  adRP. study involved human subjects, carried pre-mRNA processing eukaryotes. macromo-                  accordance tenets declaration lecular structure constituted small nuclear ribonu-            Helsinki, approved institutional review <br /> cleoproteins (snRNPs), U1, U2, U4, U5, U6,                 boards University Lausanne, Harvard Medical non-snRNP-specific proteins                     School, Massachusetts Eye Ear Infirmary. (reviewed Wahl et al.13). Intron removal spliceo-               participants gave written, informed consent occurs series sequential reactions                 donated 10&#226;&#8364;&#8220;30 ml blood genomic DNA extraction  <br /> 1 <br />  Department Medical Genetics, University Lausanne, CH-1005 Lausanne, Switzerland; 2The Berman-Gund Laboratory Study Retinal <br /> Degenerations, Harvard Medical School, Massachusetts Eye Ear Infirmary, Boston, Massachusetts 02114, USA; 3Genetics Department, IIS-Fundacio&#194;&#180;n <br /> Jime&#194;&#180;nez D&#196;&#177;&#194;&#180;az CIBERER, ES-28040 Madrid, Spain <br /> *Correspondence: carlo.rivolta@unil.ch <br /> DOI 10.1016/j.ajhg.2011.04.008. &#195;&#8220;2011 American Society Human Genetics. rights reserved. <br />  <br />  <br />  <br />  <br />                                                                  American Journal Human Genetics 88, 643&#226;&#8364;&#8220;649, 13, 2011 643 <br />  Figure 1. Schematic Partial Representation Spliceo- <br /> somal Tri-snRNP Particle Proteins Associated adRP image graphically depicts current data protein-protein <br /> interactions electron-microscopy-based physical structure tri-snRNP components. Elements U5 snRNP different shades red, belonging U4/U6 snRNP shades blue. Names proteins associated adRP white ink. dotted line indicates RP9 <br /> interacts PRPF3, core component tri-snRNP. <br />  <br />  <br />  <br /> lymphoblast immortalization. DNA regions analyzed amplified PCR primers reported Table <br /> S1, purified, subsequently sequenced standard <br /> Sanger sequencing 3100 Genetic Analyzer (Applied <br /> Biosystems, Foster City, CA). DNA <br /> changes detected (Table S2), missense variation <br /> causing arginine tryptophan (positively charged hydrophobic <span id='am-14' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-15' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-19' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span>amino acid</span>) substitution (p.Arg729Trp <br /> [c.2185C&gt;T]) codon 729 exon 16 (Figure 2A).              Figure 2. Relative Position, DNA Sequence, Effects <br /> variant, reported public sequence reposi-          c.2185C&gt;T PRPF6 <br /> tories (including 1000 Genomes project database),                 PRPF6 (red box) 21 exon gene located end long <br /> affected PRPF6 residue invariant          arm chromosome 20. c.2185C&gt;T mutation (red vertical <br />                                                                     line cDNA representation) lies exon 16 causes <br /> eukaryotic kingdoms, exception class             Arg&gt;Trp substitution codon 729. Arg729 (red pin) lies <br /> insects (Figure 2B). Arginine 729             eighth HAT (Half TRP) domain encoded <br /> HAT (half TPR) repeats present C-terminal         protein, middle PRPF6 moiety (blue bar) responsible PRPF6. domains characterized                interaction U4/U6 snRNP. <br />                                                                     (B) Phylogenetic alignment HAT domain containing <br /> presence aromatic residues conserved spacing          Arg729, indicated arrowhead. Non-conserved residues are involved protein-protein interactions.23             shaded. <br /> missense mutation present male patient European descent (<span id='am-21' about='oboInOwl:id' typeof='owl:Thing'>ID</span>: 001-173, IV-1 Figure 3A)               Additional genetic screening revealed DNA change <br /> reported family history RP absent 1,078             patient&#226;&#8364;&#8482;s affected brother; members chromosomes ethnically matched control individuals.            family available investigation (Figure 3A). <br />  <br />  <br /> 644 American Journal Human Genetics 88, 643&#226;&#8364;&#8220;649, 13, 2011 <br />                                                                          0.7 mV O.S. (lower norm &#194;&#188; 50 mV) (Figure 3C).                                                                         examined 2007 age 55. time reported                                                                         cataract surgery O.S. 1999 O.D. 2000                                                                         reoperation O.D. 2001. reoperation 2001, <br />                                                                         extensive inflammation recovered acuity <br />                                                                         O.D. acuity O.S. gradually decreased 1999 2007. <br />                                                                         noted loss peripheral vision O.U.                                                                         period. best-corrected vision hand motions <br />                                                                         O.D. 20/100 O.S. Slit-lamp examination showed pseu- <br />                                                                         dophakia O.U. Fundus examination eye showed <br />                                                                         waxy pallor disc, atrophy retinal pigment <br />                                                                         epithelium prominent choroidal vessels                                                                         macula, attenuated retinal vessels, bone spicule <br />                                                                         pigment visible midperiphery (Figure 3B, . <br />                                                                         final dark-adaptation threshold elevated 5.0 log <br />                                                                         units. visual field constricted confrontation                                                                         10  diameter O.D. 20  diameter O.S.                                                                         field ERGs (Figure 3C) response 0.5-Hz white light <br />                                                                         nondetectable  e., 1.0 mV) reduced <br />                                                                         0.26 mV O.D. 0.15 mV O.S response 30 Hz white <br />                                                                         flicker. (NB: virtual blindness, e., loss ability walk <br />                                                                         independently lighted room, occurs 30 Hz <br />                                                                         cone flicker ERG responses %0.05 mV). decline                                                                         visual acuity, visual fields, field ERG amplitudes <br />                                                                         showed considerable progression retinitis pigmen- <br />                                                                         tosa 18 years. brother 218-479 (IV-2 Figure 3A) <br />                                                                         reported had night deficiency age <br />                                                                         16 loss vision 40s. retinitis pigmentosa <br /> Figure 3. Pedigree, Fundus Photographs, Electroretino-              diagnosed age 16. years <br /> grams Patient 001-173                                                younger 001-173, vision worse   family tree index patient indicates dominant inher- <br /> itance RP  possibly  generations.                    brother gradually decreased light percep- <br /> (B) Fundus photographs patient 001-173&#226;&#8364;&#8482;s right eye age 37         tion eyes age 54. Patient 218-479   55  . Photographs reveal progression retinitis      recent eye examination, clinical records <br /> pigmentosa period  text).                                 available study. <br /> (C) field ERGs normal control patient 001-173 age 37 age 55; patient&#226;&#8364;&#8482;s responses (right eye, illustrated)         Mutations splicing-factor genes associated adRP <br /> 0.5 Hz white light flashes dark-adapted conditions            affect composition tri-snRNP 30 Hz white flicker age 55 substantially smaller            lead defects function11,16,17,20 impair <br /> responses age 37  text). Vertical lines indicate time stim-   process intron excision specific pre-mRNA <br /> ulus onset. <br />                                                                         substrates.20,24 evaluate pathogenicity identi- <br />                                                                         fied DNA change gain insights possible conse- <br />    age 37 years, patient 001-173 examined            quences heterozygous missense, immortalized (E.L.B.) 1988 night deficiency loss             lymphoblast cells patients 001-173 vision. initial examination best-              218-479 transformation Epstein-Barr virus <br /> corrected visual acuity 20/30 O.D. (right eye) 20/40             analyzed cellular localization endogenous <br /> O.S. (left eye). Slit-lamp examination showed central poste-            PRPF6. Lymphoblasts controls patients rior subcapsular cataracts O.U.  eyes). Fundus exam-            grown coverslips, fixed, costained ination eye showed normal disc, atrophy just             anti-PRPF6 antibody specific N-terminal <br /> temporal disc, clear macula, attenuated retinal arteri-          moiety (Santa Cruz Biotechnology, Santa Cruz, CA) oles, bone spicule pigment 360  periphery                antibody (Sigma-Aldrich, St. Louis, MO) recognizing <br /> (Figure 3B, . final dark adaptation threshold               SC35 protein, marker splicing speckles. Confocal <br /> elevated 3.0 log units. Goldmann visual field V-4e             microscopy revealed cell lines PRPF6 localized <br /> white test light constricted 25  diameter                 nucleoplasm splicing speckles  shown), peripheral crescent eye. field electroretino-        similar observed HeLa cells.15 <br /> grams (ERGs) substantially reduced, dark-                lymphoblasts patients revealed additional <br /> adapted mixed cone-rod responses 0.5 Hz white light               accumulation PRPF6 round sharply defined <br /> 5.6 mV O.D. 4.9 mV O.S. (lower norm &#194;&#188; 350 mV)                   subnuclear structures, identified Cajal <br /> cone responses 30 Hz white flicker 0.4 mV O.D.                bodies specific staining anti-p80-coilin <br />  <br />  <br />                                                                American Journal Human Genetics 88, 643&#226;&#8364;&#8220;649, 13, 2011 645 <br />  Figure 4. Confocal-Microscope Images PRPF6 Localization Lymphoblasts HeLa Cells <br /> Endogenous PRPF6 lymphoblasts patients 001-173 218-479 p.Arg729Trp  B, respectively) control <br /> individual (C) stained green (rabbit anti-PRPF6 donkey anti-rabbit FITC), p80-coilin shown red (mouse anti- <br /> p80-coilin donkey anti-mouse Texas red). transfected HeLa cells, fluorescence originating AcGFP-PRPF6-Arg729Trp (D) AcGFP-PRPF6-wt (E) shown green. p80-coilin (red) visualized antibodies  white bar corre- <br /> sponds 10 mm; images magnification. Yellow signals overlay images indicate accumulation PRPF6 Cajal <br /> bodies. <br />  <br />  <br /> antibody (Sigma-Aldrich) (Figures 4A 4B). did           Cajal bodies nuclei lymphoblasts occur control cells, colocalization PRPF6            patients PRPF6 p.Arg729Trp suggests p80-coilin observed (Figure 4C). Cajal                impairment tri-snRNP assembly recycling; bodies membraneless organelles involved final             impairment similar shown stages nuclear snRNP maturation14,25&#226;&#8364;&#8220;27 possibly              methods cells derived patients PRPF31, <br /> harbor tri-snRNP regeneration steps follow              PRPF3, PRPF8 mutations.20 <br /> splicing process.28 tri-snRNP assembly impaired,               gain insights process, cloned accumulation immature snRNP complexes                wild-type mutant PRPF6 length cDNA structures observed.14 Specific accumulation PRPF6          mammalian expression plasmid pAcGFP-C1 (Clontech, <br />  <br />  <br /> 646 American Journal Human Genetics 88, 643&#226;&#8364;&#8220;649, 13, 2011 <br />                                                                      displayed cells naturally occurring p.Arg729Trp <br />                                                                     AcGFP-PRPF6-mut partly avoided splicing <br />                                                                     speckles (Figure S1) localized, unlike AcGFP-PRPF6- <br />                                                                     wild-type, Cajal bodies (Figures 4D 4E).                                                                     data demonstrate mislocalized PRPF6 concerns                                                                     mutated protein endogenous functional copies <br />                                                                     PRPF6 HeLa complement phenotype. <br />                                                                        previously demonstrated patients                                                                     mutations PRPF31, PRPF3, PRPF8 fail correctly <br />                                                                     splice introns pre-mRNAs probably carry specific, <br />                                                                     unidentified, signals primary sequences.20 <br />                                                                     Specifically, cell lines seven patients different <br />                                                                     mutations RP genes unable completely <br />                                                                     excise &#226;&#8364;&#732;&#226;&#8364;&#732;signature&#226;&#8364;&#8482;&#226;&#8364;&#8482; introns, panel 57 endoge- <br />                                                                     nously transcribed sequences recapitulated                                                                     majority splicing signals detected far humans                                                                     displaying wide range gene expression. According                                                                     recently proposed model disease, deficiency <br />                                                                     mRNA maturation lead accumulation defec- <br />                                                                     tive transcripts proteins step molecular <br /> Figure 5. RT-PCRs Selected Endogenously Expressed Tran-          pathology RP.20 Strikingly, analyzed ability <br /> scripts Lymphoblasts Controls, Patients p.Arg729Trp, Patients PRPF31, PRPF3,             process panel 57 introns, cell lines <br /> PRPF8 Mutations                                                     p.Arg729Trp displayed incomplete excision panel RT-PCRs encompassing introns previously    signature introns (Figure 5). data indicate partially unspliced lymphoblasts patients PRPF31,   PRPF6 mutation effect PRPF3, PRPF8 mutations shown. Lane 1, molecular size <br /> marker (Promega, Cat #G2101); lanes 2&#226;&#8364;&#8220;16, lymphoblasts         spliceosomal composition general pre-mRNA <br /> 15 control individuals; lane 17, lymphoblasts patient          processing. Furthermore, strongly indicate 001-173; lane 18, lymphoblasts patient 218-479; lanes          PRPF6 true RP gene; cells p.Arg729Trp defective <br /> 19&#226;&#8364;&#8220;21, lymphoblasts patients mutations PRPF31,         excising specific introns incorrectly <br /> PRPF3, PRPF8 (positive controls). RT-PCRs performed HIST3H3 represent technical negative controls gene     processed patients PRPF-associated RP. intronless. E#: exon harboring forward reverse RT-PCR        conclusion, identify PRPF6 sixth splicing- <br /> primer. Arrowheads indicate unspliced products.                     factor gene involved autosomal-dominant retinitis pig- <br />                                                                     mentosa. mutation detected proband Mountain View, CA) produce PRPF6 fusion protein                affected brother missense mutation, green fluorescent protein  coerulescens             DNA changes detected far RP genes <br /> (AcGFP). Specifically, cDNA control human                    associated tri-snRNP. concerns uniquely <br /> lymphoblast library amplified PCR proof-            conserved residue HAT domain reading Pfu DNA polymerase (Promega, Madison, WI)                   U4/U6 snRNP interaction region21 primers 50 -CGGAATTCCATGAACAAGAAGAAG-30                         affect PRPF6 binding di-snRNP. presently 50 -GGGGTACCTCAGAAGGTGTT-30 . matched                     unclear mutated PRPF6 alleles act hap- PRPF6 sequence 30 moiety carried artifi-           loinsufficient dominant-negative elements. <br /> cially introduced restriction sites (underlined)               hypotheses linking defects splicing- <br /> EcoRI KpnI endonucleases, respectively,                factor genes RP proposed (e.g.20,24,29&#226;&#8364;&#8220;31), <br /> 50 end. used restriction sites clone PCR prod-          incorporated general models. <br /> ucts pAcGFP-C1 produce plasmid AcGFP-                  model postulates misplicing events affecting <br /> PRPF6-wild-type. introduced p.Arg729Trp change               mRNAs retina specific directly related RP plasmid following QuickChange               (e.g., rhodopsin). second proposes splicing defects <br /> Site-Directed Mutagenesis protocol (Agilent Technologies,           touch widely expressed transcripts La Jolla, CA) using mutagenesis primers 50 -GATGATG             affected cell lines patients, GAGAAGGCGTGGGAAGCCTATAACC-30 50 -GGTTA                          clear-cut relationship retinal physiology TAGGCTTCCCACGCCTTCTCCATCATC-30  nucleo-                         shown. case, RP consequence tide carrying mutation underlined) obtain plasmid         increased susceptibility retina general reduction <br /> AcGFP-PRPF6-Arg729Trp. sequence cloned DNA               splicing activity continuous accumulation assessed direct <span id='am-6' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-12' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> sequencing,            defective gene products. results verified contain unwanted variants. Imagery              clearly sustain model  fit HeLa cells transfected constructs revealed            second better, certainly highlight mutant fusions produced phenotype                 central role tri-snRNP molecular etiology RP. <br />                                                             member pre-mRNA splicing factor genes, implicated                                                                                  autosomal dominant retinitis pigmentosa. Hum. Mol. Genet. <br /> </body></html>